Company Filing History:
Years Active: 2011-2013
Title: **Innovations of Frans M A Van Den Keybus in Pharmaceutical Patents**
Introduction
Frans M A Van Den Keybus, an accomplished inventor based in Beerse, Belgium, has made significant contributions to the field of pharmaceutical innovations. With a total of 2 patents to his name, his work focuses on developing therapeutic agents targeting critical health issues. His latest inventions demonstrate his commitment to advancing medical science and improving patient outcomes.
Latest Patents
The latest patents by Frans M A Van Den Keybus include:
1. **Pyrrolopyridine derivatives substituted with cyclic amino group**: This invention addresses the need for an effective antagonist against CRF receptors. It aims to serve as a therapeutic or prophylactic agent for various diseases associated with CRF, such as depression, anxiety, Alzheimer's disease, and more. The pyrrolopyrimidine or pyrrolopyridine derivative depicted in this patent is noted for its high affinity for CRF receptors, offering hope for treating numerous challenging medical conditions.
2. **Pyrrolo[2,3-d]pyrimidine derivatives substituted with a cyclic amino group**: Similarly focused on CRF receptors, this patent introduces another innovative compound that promises to be effective against diseases like schizophrenia, epilepsy, and inflammation, among others. These derivatives present a novel approach to tackling disorders where CRF plays a vital role, showcasing the potential of targeted therapeutic strategies.
Career Highlights
Frans M A Van Den Keybus has dedicated his career to research and development at Taisho Pharmaceutical Co., Ltd. His innovative spirit and extensive knowledge in medicinal chemistry have established him as a notable figure in pharmaceutical research. His inventions are a testament to his relentless pursuit of solutions for complex medical challenges.
Collaborations
Throughout his career, Frans has collaborated with esteemed colleagues such as Atsuro Nakazato and Taketoshi Okubo. These partnerships have amplified his research capabilities and contributed to the progress of the projects he has undertaken. Together, they have explored novel pathways in drug development, furthering the field of therapeutic agents.
Conclusion
Frans M A Van Den Keybus's contributions to pharmaceutical inventions through his patents reflect a dedicated effort to combat serious health conditions. His innovative work not only highlights his ingenuity as an inventor but also provides valuable insights into potential therapies that can significantly impact patients' lives. With a focus on CRF receptors, his latest patents hold promise for the future of medical advancements in treating a variety of challenging disorders.